{"id":783890,"date":"2022-05-04T08:05:21","date_gmt":"2022-05-04T06:05:21","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/"},"modified":"2023-07-11T15:20:32","modified_gmt":"2023-07-11T13:20:32","slug":"ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/","title":{"rendered":"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today"},"content":{"rendered":"GOSSELIES, Belgium--(BUSINESS WIRE)--#cellistic--Ncardia has launched a new business, Cellistic\u2122, to focus Ncardia\u2019s induced pluripotent stem cell (iPSC) expertise on the cell therapy development and manufacturing sector. This strategy expands on Ncardia\u2019s existing drug discovery solutions business and capitalizes on the company\u2019s deep expertise in iPSC differentiation and expansion to focus dedicated resources and capabilities to address the growing need for iPSC cell therapy solutions, including the development of robust cell-specific manufacturing platforms.\n\n\n\nThe development of cell therapies derived from iPSCs offers the possibility of effective treatments for many diseases and reducing the cost and complexity of current autol<div class=\"leaky_paywall_message_wrap\"><div id=\"leaky_paywall_message\"><a href=\"https:\/\/bebeez.it\/abbonati\/\">Abbonati<\/a> o <a href=\"https:\/\/bebeez.it\/mio-account\/\">Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>GOSSELIES, Belgium&#8211;(BUSINESS WIRE)&#8211;#cellistic&#8211;Ncardia has launched a new business, Cellistic\u2122, to focus Ncardia\u2019s induced pluripotent stem cell (iPSC) expertise on the cell therapy development and manufacturing sector. This strategy expands on Ncardia\u2019s existing drug discovery solutions business and capitalizes on the company\u2019s deep expertise in iPSC differentiation and expansion to focus dedicated resources and capabilities to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49624],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-783890","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-europe"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BeBeez\" \/>\n<meta property=\"og:description\" content=\"GOSSELIES, Belgium--(BUSINESS WIRE)--#cellistic--Ncardia has launched a new business, Cellistic\u2122, to focus Ncardia\u2019s induced pluripotent stem cell (iPSC) expertise on the cell therapy development and manufacturing sector. This strategy expands on Ncardia\u2019s existing drug discovery solutions business and capitalizes on the company\u2019s deep expertise in iPSC differentiation and expansion to focus dedicated resources and capabilities to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-04T06:05:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-11T13:20:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"olomaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"olomaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/\"},\"author\":{\"name\":\"olomaster\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\"},\"headline\":\"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today\",\"datePublished\":\"2022-05-04T06:05:21+00:00\",\"dateModified\":\"2023-07-11T13:20:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/\"},\"wordCount\":855,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in Europe\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/\",\"name\":\"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-05-04T06:05:21+00:00\",\"dateModified\":\"2023-07-11T13:20:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\",\"name\":\"olomaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"caption\":\"olomaster\"},\"url\":\"https:\/\/bebeez.it\/en\/author\/olomaster\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/","og_locale":"en_US","og_type":"article","og_title":"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BeBeez","og_description":"GOSSELIES, Belgium--(BUSINESS WIRE)--#cellistic--Ncardia has launched a new business, Cellistic\u2122, to focus Ncardia\u2019s induced pluripotent stem cell (iPSC) expertise on the cell therapy development and manufacturing sector. This strategy expands on Ncardia\u2019s existing drug discovery solutions business and capitalizes on the company\u2019s deep expertise in iPSC differentiation and expansion to focus dedicated resources and capabilities to [&hellip;]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/","og_site_name":"BeBeez","article_published_time":"2022-05-04T06:05:21+00:00","article_modified_time":"2023-07-11T13:20:32+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"author":"olomaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"olomaster","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/"},"author":{"name":"olomaster","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518"},"headline":"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today","datePublished":"2022-05-04T06:05:21+00:00","dateModified":"2023-07-11T13:20:32+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/"},"wordCount":855,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in Europe"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/","name":"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-05-04T06:05:21+00:00","dateModified":"2023-07-11T13:20:32+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-europe\/ncardia-launches-cellistic-the-only-ipsc-based-cell-therapy-process-development-manufacturing-partner-purpose-built-to-make-large-scale-allogeneic-cell-therapy-production-a-reality-tod\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Ncardia Launches Cellistic\u2122, the Only iPSC-based Cell Therapy Process Development &amp; Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518","name":"olomaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","caption":"olomaster"},"url":"https:\/\/bebeez.it\/en\/author\/olomaster\/"}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/783890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=783890"}],"version-history":[{"count":1,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/783890\/revisions"}],"predecessor-version":[{"id":890102,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/783890\/revisions\/890102"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=783890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=783890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=783890"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=783890"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=783890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}